Engineered calprotectin-sensing probiotics for IBD surveillance in humans.
Ontology highlight
ABSTRACT: Inflammatory bowel disease (IBD) is a spectrum of autoimmune diseases affecting the gastrointestinal tract characterized by a relapsing and remitting course of gut mucosal inflammation. Disease flares can be difficult to predict, and the current practice of IBD disease activity surveillance through endoscopy is invasive and requires medical expertise. Recent advancements in synthetic biology raise the possibility that symbiotic microbes can be engineered to selectively detect disease biomarkers used in current clinical practice. Here, we introduce an engineered probiotic capable of detecting the clinical gold standard IBD biomarker, calprotectin, with sensitivity and specificity in IBD patients. Specifically, we identified a bacterial promoter in the probiotic strain Escherichia coli
SUBMITTER: Xia JY
PROVIDER: S-EPMC10410751 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA